Elisabeth Dohin

1.3k total citations
27 papers, 767 citations indexed

About

Elisabeth Dohin is a scholar working on Epidemiology, Neurology and Infectious Diseases. According to data from OpenAlex, Elisabeth Dohin has authored 27 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Neurology and 7 papers in Infectious Diseases. Recurrent topics in Elisabeth Dohin's work include Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (6 papers) and HIV/AIDS drug development and treatment (6 papers). Elisabeth Dohin is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (9 papers), Neurological disorders and treatments (6 papers) and HIV/AIDS drug development and treatment (6 papers). Elisabeth Dohin collaborates with scholars based in France, Germany and United States. Elisabeth Dohin's co-authors include Christine Katlama, Lars Bauer, M Gentilini, Mahnaz Asgharnejad, Erwin Surmann, К. Ray Chaudhuri, Olivier Rascol, Martin Danis, Franck Martinez and Gilbert Deray and has published in prestigious journals such as Neurology, Journal of Allergy and Clinical Immunology and Journal of Clinical Microbiology.

In The Last Decade

Elisabeth Dohin

27 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabeth Dohin France	14	360	235	175	92	88	27	767
Pria Anand United States	12	100 0.3×	278 1.2×	207 1.2×	53 0.6×	35 0.4×	48	638
Taylor Harrison United States	12	229 0.6×	232 1.0×	106 0.6×	98 1.1×	44 0.5×	29	688
Lokesh Shahani United States	14	172 0.5×	60 0.3×	165 0.9×	53 0.6×	30 0.3×	54	527
Paola Morelli Italy	16	100 0.3×	231 1.0×	226 1.3×	92 1.0×	12 0.1×	32	710
Sirianong Namwongprom Thailand	15	125 0.3×	25 0.1×	169 1.0×	36 0.4×	27 0.3×	38	579
Daniel Lee United States	11	307 0.9×	182 0.8×	144 0.8×	101 1.1×	6 0.1×	30	631
Sergio Ferrara Italy	13	95 0.3×	29 0.1×	196 1.1×	125 1.4×	19 0.2×	64	442
Vincenzo Pisani Italy	12	339 0.9×	65 0.3×	60 0.3×	9 0.1×	70 0.8×	25	650
George Panayiotakopoulos Greece	13	93 0.3×	31 0.1×	103 0.6×	32 0.3×	29 0.3×	39	633
Christopher Whalen United States	9	542 1.5×	15 0.1×	623 3.6×	217 2.4×	24 0.3×	12	1.2k

Countries citing papers authored by Elisabeth Dohin

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Dohin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Dohin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Dohin more than expected).

Fields of papers citing papers by Elisabeth Dohin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Dohin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Dohin. The network helps show where Elisabeth Dohin may publish in the future.

Co-authorship network of co-authors of Elisabeth Dohin

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Dohin. A scholar is included among the top collaborators of Elisabeth Dohin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Dohin. Elisabeth Dohin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Giladi, Nir, Anthony P. Nicholas, Mahnaz Asgharnejad, et al.. (2016). Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage. Journal of Parkinson s Disease. 6(4). 741–749. 13 indexed citations

Dauvilliers, Yves, Heike Beneš, Markku Partinen, et al.. (2016). Rotigotine in Hemodialysis-Associated Restless Legs Syndrome: A Randomized Controlled Trial. American Journal of Kidney Diseases. 68(3). 434–443. 33 indexed citations

Hauser, Robert A., Jarosław Sławek, Paolo Barone, et al.. (2016). Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease. BMC Neurology. 16(1). 90–90. 46 indexed citations

García‐Borreguero, Diego, Richard P. Allen, Elisabeth Dohin, et al.. (2015). Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study. Current Medical Research and Opinion. 32(1). 77–85. 13 indexed citations

Winkelman, John W., Yves Dauvilliers, Markku Partinen, et al.. (2015). Rotigotine in Patients with Restless Legs Syndrome and End-stage Renal Disease Requiring Hemodialysis (P7.298). Neurology. 84(14_supplement). 2 indexed citations

Timmermann, Lars, Mahnaz Asgharnejad, Babak Boroojerdi, et al.. (2015). Impact of 6-month earlier versus postponed initiation of rotigotine on long-term outcome:post hocanalysis of patients with early Parkinson’s disease with mild symptom severity. Expert Opinion on Pharmacotherapy. 16(10). 1423–1433. 6 indexed citations

Antonini, Angelo, Lars Bauer, Elisabeth Dohin, et al.. (2015). Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial. European Journal of Neurology. 22(10). 1400–1407. 57 indexed citations

Dohin, Elisabeth, Birgit Högl, Luigi Ferini‐Strambi, et al.. (2012). Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: apost-hocanalysis of patients taking 1 – 3 mg/24 h for up to 5 years. Expert Opinion on Pharmacotherapy. 14(1). 15–25. 10 indexed citations

Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né. Therapies. 61(4). 287–295. 2 indexed citations

10.

Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Risk Management and Monitoring Methods for the Future Mother, Embryo, Fetus, and post-natal Consequences. Therapies. 61(4). 297–304. 2 indexed citations

11.

Bergmann, Jean‐François, et al.. (2002). [Compliance, efficacy and quality of life].. PubMed. 57(4). 366–78. 5 indexed citations

12.

Katlama, Christine, D. Lacoste, C. Aquilina, et al.. (2001). MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine. HIV Medicine. 2(1). 20–26. 4 indexed citations

13.

Forestier, François, et al.. (2001). Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. American Journal of Obstetrics and Gynecology. 185(1). 178–181. 52 indexed citations

14.

Michelet, C., Annick Ruffault, Véronique Sebille, et al.. (2001). Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients. Antimicrobial Agents and Chemotherapy. 45(12). 3393–3402. 7 indexed citations

15.

Demoly, Pascal, D. Messaad, Aldo Trylesinski, et al.. (1998). Nelfinavir-induced urticaria and successful desensitization. Journal of Allergy and Clinical Immunology. 102(5). 875–876. 17 indexed citations

16.

Vittecoq, Daniel, Guy G. Simoneau, Laura Dumitrescu, et al.. (1997). Pharmacokinetic of saquinavir and study of intestinal function in HIV patients. 37. 2. 1 indexed citations

17.

Leplège, Alain, et al.. (1997). Measuring quality of life from the point of view of HIV-positive subjects: the HIV-QL31. Quality of Life Research. 6(6). 585–594. 48 indexed citations

18.

Blanshard, C, et al.. (1995). Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison. The Journal of Infectious Diseases. 172(3). 622–628. 70 indexed citations

19.

Gabarre, Jean, Nabih Azar, Tarek Ben Othman, et al.. (1992). [Long-term effects of splenectomy for immune thrombopenic purpura related to human immunodeficiency virus. A retrospective study from 2 groups, with and without splenectomy].. PubMed. 20(44). 2239–45. 4 indexed citations

20.

Deray, Gilbert, Franck Martinez, Christine Katlama, et al.. (1989). Foscarnet Nephrotoxicity: Mechanism, Incidence and Prevention. American Journal of Nephrology. 9(4). 316–321. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact